Colon-Otero G - Search Results

1

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.

Chumsri S, Li Z, Serie DJ, Mashadi-Hossein A, Colon-Otero G, Song N, Pogue-Geile KL, Gavin PG, Paik S, Moreno-Aspitia A, Perez EA, Thompson EA. Chumsri S, et al. J Clin Oncol. 2019 Dec 10;37(35):3425-3435. doi: 10.1200/JCO.19.00443. Epub 2019 Oct 17. J Clin Oncol. 2019. PMID: 31622131 Free PMC article. Clinical Trial.

2

Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial.

Witzig TE, Letendre L, Gerstner J, Schroeder G, Mailliard JA, Colon-Otero G, Marschke RF, Windschitl HE. Witzig TE, et al. J Clin Oncol. 1995 Aug;13(8):2012-5. doi: 10.1200/JCO.1995.13.8.2012. J Clin Oncol. 1995. PMID: 7636542 Clinical Trial.

3

Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.

O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE. O'Connell MJ, et al. J Clin Oncol. 1998 Jul;16(7):2528-33. doi: 10.1200/JCO.1998.16.7.2528. J Clin Oncol. 1998. PMID: 9667274 Clinical Trial.

4

A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.

Colon-Otero G, Niedringhaus RD, Hillman SH, Geyer S, Sloan J, Krook JE, Windschitl HE, Marks RS, Wiesenfeld M, Tschetter LK, Jett JJ; North Central Cancer Treatment Group. Colon-Otero G, et al. Am J Clin Oncol. 2001 Dec;24(6):551-5. doi: 10.1097/00000421-200112000-00004. Am J Clin Oncol. 2001. PMID: 11801752 Clinical Trial.

5

Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trial.

Moreno-Aspitia A, Colon-Otero G, Hoering A, Tefferi A, Niedringhaus RD, Vukov A, Li CY, Menke DM, Geyer SM, Alberts SR; North Central Cancer Treatment Group. Moreno-Aspitia A, et al. Cancer. 2006 Aug 15;107(4):767-72. doi: 10.1002/cncr.22047. Cancer. 2006. PMID: 16826578 Free article. Clinical Trial.

6

Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.

Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Zubair AC, et al. Transfusion. 2008 Jun;48(6):1106-14. doi: 10.1111/j.1537-2995.2008.01651.x. Epub 2008 Feb 25. Transfusion. 2008. PMID: 18315528 Free PMC article.

7

Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population.

Palmieri FM, DePeri ER, Mincey BA, Smith JA, Wen LK, Chewar DM, Abaya R, Colon-Otero G, Perez EA. Palmieri FM, et al. Mayo Clin Proc. 2009 Apr;84(4):317-22. doi: 10.1016/S0025-6196(11)60539-9. Mayo Clin Proc. 2009. PMID: 19339648 Free PMC article.

8

Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups.

Patel TA, Colon-Otero G, Bueno Hume C, Copland JA 3rd, Perez EA. Patel TA, et al. Oncologist. 2010;15(5):466-75. doi: 10.1634/theoncologist.2010-0004. Epub 2010 Apr 28. Oncologist. 2010. PMID: 20427382 Free PMC article. Review.

9

Increased incidence of loco-regional recurrences among african american women with terminal stage breast cancer.

Colón-Otero G, King S, Smith V, Bieber C, Crook J, Solberg LA, Shannon R, Perez EA. Colón-Otero G, et al. Clin Med Oncol. 2008;2:547-50. doi: 10.4137/cmo.s988. Epub 2008 Nov 3. Clin Med Oncol. 2008. PMID: 21892330 Free PMC article.

10

Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers.

Cooper SJ, von Roemeling CA, Kang KH, Marlow LA, Grebe SK, Menefee ME, Tun HW, Colon-Otero G, Perez EA, Copland JA. Cooper SJ, et al. Mol Cancer Ther. 2012 Oct;11(10):2105-15. doi: 10.1158/1535-7163.MCT-11-0873. Epub 2012 Jul 23. Mol Cancer Ther. 2012. PMID: 22826467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page